These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6093295)

  • 1. Use of Epstein-Barr virus to transform fetal human spleen cells for HLA typing.
    Mandel TE; Tait BD
    Transplantation; 1984 Oct; 38(4):436-7. PubMed ID: 6093295
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA-DR typing of fetal human spleen and liver lymphoblastoid cells transformed by Epstein-Barr virus.
    Mandel TE; Jack I; Tait BD
    Transplantation; 1982 Jul; 34(1):50-3. PubMed ID: 6289497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of circulating maternal T and B lymphocytes in uncomplicated severe combined immunodeficiency by HLA typing of subpopulations of T cells separated by the fluorescence-activated cell sorter and of Epstein Barr virus-derived B cell lines.
    Geha RS; Reinherz E
    J Immunol; 1983 Jun; 130(6):2493-5. PubMed ID: 6304187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergy between anti-CD40 MAb and Epstein-Barr virus in activation and transformation of human B lymphocytes.
    Tsuchiyama L; Kieran J; Boyle P; Wetzel GD
    Hum Antibodies; 1997; 8(1):43-7. PubMed ID: 9265505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus-induced lymphoblastoid cell lines from seropositive adult donors and their HLA-antigens.
    Akiyama N; Ohsawa N; Kusaba R; Inou T; Takada M
    Jpn J Exp Med; 1981 Feb; 51(1):1-7. PubMed ID: 6273617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Provision of Epstein-Barr virus-transformed B-cell lines in a routine tissue typing laboratory: practicalities and applications.
    Bass H; Walters R; Darke C
    Eur J Immunogenet; 2004 Apr; 31(2):87-92. PubMed ID: 15086349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T-cell hybrids with HLA-restricted proliferative response to Epstein-Barr virus-infected B cells.
    Gallagher G; Stimson WH
    Immunology; 1984 Dec; 53(4):611-21. PubMed ID: 6209205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cells under influence: transformation of B cells by Epstein-Barr virus.
    Küppers R
    Nat Rev Immunol; 2003 Oct; 3(10):801-12. PubMed ID: 14523386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-typing of fetal cells using interferon treatment in vitro.
    Royo C; Touraine JL; Betuel H
    Prog Clin Biol Res; 1985; 193():149-55. PubMed ID: 3911209
    [No Abstract]   [Full Text] [Related]  

  • 10. Human dendritic cells pulsed with autologous Epstein-Barr virus transformed B-cell lymphoblastoid cell (BCL) lysate elicit a BCL specific MHC-class II restricted T-cell response.
    Sugano M; Conway TF; Kelleher RJ; Sugiyama Y; Chen FA; Bankert RB; Bernstein SH
    J Exp Clin Cancer Res; 2001 Jun; 20(2):175-82. PubMed ID: 11484971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus infection of rat lymphocytes expressing human CD21 results in restricted latent viral gene expression and not in immunoblastic transformation.
    Yang L; Ikeda H; Lai Y; Yoshiki T; Takada K
    J Med Virol; 2003 May; 70(1):126-30. PubMed ID: 12629653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody to the Epstein-Barr virus receptor induces human B lymphocyte activation and differentiation.
    Nemerow GR; McNaughton ME; Cooper NR
    Trans Assoc Am Physicians; 1985; 98():290-300. PubMed ID: 3022444
    [No Abstract]   [Full Text] [Related]  

  • 13. Cross-killing phenomenon during induction of cytotoxic activity against autologous leukemic cells or autologous Epstein-Barr virus-transformed lymphoblastoid B-cell line.
    Maeda Y; Hijikata Y; Yamaguchi T; Morita Y; Kanamaru A
    Leuk Res; 2008 Mar; 32(3):510-1. PubMed ID: 17628665
    [No Abstract]   [Full Text] [Related]  

  • 14. Specific human alloantibody produced by Epstein-Barr virus transformation of infiltrating cells from a rejected kidney graft.
    Finnemore AM; Horsburgh T; Mistry N; Bell PR
    Transplant Proc; 1990 Oct; 22(5):2288. PubMed ID: 2171168
    [No Abstract]   [Full Text] [Related]  

  • 15. HLA-G expression is induced in Epstein-Barr virus-transformed B-cell lines by culture conditions.
    Gazit E; Sherf M; Balbin E; Muratov A; Goldstein I; Loewenthal R
    Hum Immunol; 2007 Jun; 68(6):463-8. PubMed ID: 17509445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell transformation induced by Epstein-Barr virus--living dangerously.
    Rowe M
    Semin Cancer Biol; 2001 Dec; 11(6):403-5. PubMed ID: 11669601
    [No Abstract]   [Full Text] [Related]  

  • 17. Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus.
    Borza CM; Hutt-Fletcher LM
    Nat Med; 2002 Jun; 8(6):594-9. PubMed ID: 12042810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of monoclonal antibodies to an EBV transformed B-cell line.
    Schröder J; Suomalainen HA; Parkkinen E; Lundqvist C; Wada G; Koskimies S
    Med Biol; 1982 Oct; 60(5):255-9. PubMed ID: 6296556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-D typing using Epstein-Barr virus-induced lymphoblastoid cell lines.
    Akiyama N; Ohsawa N; Samaru Y; Kusaba R
    Jpn J Exp Med; 1982 Apr; 52(2):67-73. PubMed ID: 6288983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA typing of human fetuses.
    Delfini C; De Biagi M; Nesci S; Donati M; Lucarelli G
    Haematologica; 1982 Jun; 67(3):489-90. PubMed ID: 6815009
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.